News

Filter by Topic
Filter by Topic
Mirai Medical’s ePORE® therapy with EndoVE® is launched in Spain
Read More
Mirai Medical launch EndoVE® probe in Leeds
Read More
Mirai Medical Launches its New Website and has Received a Favourable Ethical Opinion for the PIONEER Patient Registry
Read More
First Patient Enrolled in VECTOR Trial using ePORE® therapy for the Treatment of Inoperable Oesophageal and Gastric Cancer
Read More
Galway-based Mirai Medical raises €3m in funding
Read More
Endoscopic electrochemotherapy for Oesophageal cancer: a phase I clinical study
Read More
Phase one Study on electrochemotherapy for colorectal cancer using endoscopic electroporation
Read More

Contact Us

By clicking send, you confirm you have read and agreed to Mirai Medical's Privacy Policy.
Twitter Linkedin-in Youtube
ePORE Therapy White Logo
Address:
Mirai Medical
Unit 5, Howley Court
Oranmore
Galway
Ireland
Email:
info@mirai-medical.com
Mirai Medical logo white
© Copyright 2024 MIRAI MEDICAL. All Rights Reserved.
Privacy & Cookies
ePORE® therapy, EndoVE® and CUTIS are approved for commercialisation in the European Union, United Kingdom and Australia. ePORE® therapy, EndoVE® and CUTIS are not cleared by FDA for commercialisation in the USA.
WEEE Ireland Certificate of Registration MIR 100
PRL Registration Number: IE 02581 WB
Website by Proactive Design & Marketing